HSP90AA1 and breast carcinoma: The intense Hsp90 immunoreactivity detected in our cases suggests that this protein could represent a novel molecular target for adjuvant cancer treatment of canine mammary tumours, and this animal model could be studied for further testing new breast cancer therapy.